These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1080 related items for PubMed ID: 21998214

  • 1. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
    Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C, Travaglino E, Groves MJ, Godfrey AL, Ambaglio I, Gallì A, Da Vià MC, Conte S, Tauro S, Keenan N, Hyslop A, Hinton J, Mudie LJ, Wainscoat JS, Futreal PA, Stratton MR, Campbell PJ, Hellström-Lindberg E, Cazzola M, Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium and of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative.
    Blood; 2011 Dec 08; 118(24):6239-46. PubMed ID: 21998214
    [Abstract] [Full Text] [Related]

  • 2. Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.
    Malcovati L, Papaemmanuil E, Ambaglio I, Elena C, Gallì A, Della Porta MG, Travaglino E, Pietra D, Pascutto C, Ubezio M, Bono E, Da Vià MC, Brisci A, Bruno F, Cremonesi L, Ferrari M, Boveri E, Invernizzi R, Campbell PJ, Cazzola M.
    Blood; 2014 Aug 28; 124(9):1513-21. PubMed ID: 24970933
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of SF3B1 mutations in Korean patients with myelodysplastic syndromes and myelodysplasia/myeloproliferative neoplasms with ring sideroblasts.
    Seo JY, Lee KO, Kim SH, Kim K, Jung CW, Jang JH, Kim HJ.
    Ann Hematol; 2014 Apr 28; 93(4):603-8. PubMed ID: 24141330
    [Abstract] [Full Text] [Related]

  • 4. Many faces of SF3B1-mutated myeloid neoplasms: concurrent mutational profiles contribute to the diverse clinical and morphologic features.
    Aqil B, Sukhanova M, Behdad A, Jennings L, Lu X, Chen Q, Chen YH, Gao J.
    Hum Pathol; 2022 Nov 28; 129():81-89. PubMed ID: 36087739
    [Abstract] [Full Text] [Related]

  • 5. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.
    Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, Jädersten M, Jansson M, Elena C, Gallì A, Walldin G, Della Porta MG, Raaschou-Jensen K, Travaglino E, Kallenbach K, Pietra D, Ljungström V, Conte S, Boveri E, Invernizzi R, Rosenquist R, Campbell PJ, Cazzola M, Hellström Lindberg E.
    Blood; 2015 Jul 09; 126(2):233-41. PubMed ID: 25957392
    [Abstract] [Full Text] [Related]

  • 6. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
    Zhu Y, Li X, Chang C, Xu F, He Q, Guo J, Tao Y, Liu Y, Liu L, Shi W.
    Leuk Res; 2016 May 09; 44():8-16. PubMed ID: 26970172
    [Abstract] [Full Text] [Related]

  • 7. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors.
    Je EM, Yoo NJ, Kim YJ, Kim MS, Lee SH.
    Int J Cancer; 2013 Jul 09; 133(1):260-5. PubMed ID: 23280334
    [Abstract] [Full Text] [Related]

  • 8. Refractory anemia with ring sideroblasts.
    Malcovati L, Cazzola M.
    Best Pract Res Clin Haematol; 2013 Dec 09; 26(4):377-85. PubMed ID: 24507814
    [Abstract] [Full Text] [Related]

  • 9. Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis.
    Migdady Y, Barnard J, Al Ali N, Steensma DP, DeZern A, Roboz G, Garcia-Manero G, Sekeres MA, Komrokji RS.
    Clin Lymphoma Myeloma Leuk; 2018 Aug 09; 18(8):528-532. PubMed ID: 29937400
    [Abstract] [Full Text] [Related]

  • 10. The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm.
    Ibrar W, Zhang W, Cox JL, Cushman-Vokoun A, Fu K, Greiner TC, Yuan J.
    Int J Lab Hematol; 2021 Dec 09; 43(6):1501-1509. PubMed ID: 34270867
    [Abstract] [Full Text] [Related]

  • 11. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms.
    Todisco G, Creignou M, Gallì A, Guglielmelli P, Rumi E, Roncador M, Rizzo E, Nannya Y, Pietra D, Elena C, Bono E, Molteni E, Rosti V, Catricalá S, Sarchi M, Dimitriou M, Ungerstedt J, Vannucchi AM, Hellström-Lindberg E, Ogawa S, Cazzola M, Malcovati L.
    Leukemia; 2021 Aug 09; 35(8):2371-2381. PubMed ID: 33349666
    [Abstract] [Full Text] [Related]

  • 12. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.
    Cazzola M, Rossi M, Malcovati L, Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative.
    Blood; 2013 Jan 10; 121(2):260-9. PubMed ID: 23160465
    [Abstract] [Full Text] [Related]

  • 13. Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.
    Farrukh F, Abdelmagid M, Mangaonkar A, Patnaik M, Al-Kali A, Elliott MA, Begna KH, Hook CC, Hogan WJ, Pardanani A, Litzow MR, Ketterling RP, Gangat N, Arber DA, Orazi A, He R, Reichard K, Tefferi A.
    Haematologica; 2024 Aug 01; 109(8):2525-2532. PubMed ID: 38450522
    [Abstract] [Full Text] [Related]

  • 14. Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.
    Sallman DA, Komrokji R, Vaupel C, Cluzeau T, Geyer SM, McGraw KL, Al Ali NH, Lancet J, McGinniss MJ, Nahas S, Smith AE, Kulasekararaj A, Mufti G, List A, Hall J, Padron E.
    Leukemia; 2016 Mar 01; 30(3):666-73. PubMed ID: 26514544
    [Abstract] [Full Text] [Related]

  • 15. Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes.
    Patel JL, Abedi M, Cogle CR, Erba HP, Foucar K, Garcia-Manero G, Grinblatt DL, Komrokji RS, Kurtin SE, Maciejewski JP, Pollyea DA, Revicki DA, Roboz GJ, Savona MR, Scott BL, Sekeres MA, Steensma DP, Thompson MA, Dawn Flick E, Kiselev P, Louis CU, Nifenecker M, Swern AS, George TI.
    Int J Lab Hematol; 2021 Jun 01; 43(3):426-432. PubMed ID: 33220019
    [Abstract] [Full Text] [Related]

  • 16. Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts.
    Cui R, Gale RP, Xu Z, Qin T, Fang L, Zhang H, Pan L, Zhang Y, Xiao Z.
    Leuk Res; 2012 Nov 01; 36(11):1428-33. PubMed ID: 22921018
    [Abstract] [Full Text] [Related]

  • 17. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts.
    Kang MG, Kim HR, Seo BY, Lee JH, Choi SY, Kim SH, Shin JH, Suh SP, Ahn JS, Shin MG.
    BMC Cancer; 2015 Jun 27; 15():484. PubMed ID: 26115659
    [Abstract] [Full Text] [Related]

  • 18. JAK2/CALR/SF3B1 triple-mutated myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis evolving to myelofibrosis and SF3B1 single-mutated acute myeloid leukemia: Evidence of a pre-JAK2 clone.
    Yasuda H, Morishita S, Mori Y, Tsukune Y, Inano T, Harada S, Komatsu N.
    Leuk Res; 2021 Jan 27; 100():106496. PubMed ID: 33373831
    [No Abstract] [Full Text] [Related]

  • 19. SF3B1 Mutation but Not Ring Sideroblasts Identifies a Specific Group of Myelodysplastic Syndrome-Refractory Cytopenia With Multilineage Dysplasia.
    Xiong B, Xue M, Yu Y, Wu S, Zuo X.
    Clin Lymphoma Myeloma Leuk; 2020 May 27; 20(5):329-339.e3. PubMed ID: 32037286
    [Abstract] [Full Text] [Related]

  • 20. Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management".
    Patnaik MM, Tefferi A.
    Am J Hematol; 2021 Mar 01; 96(3):379-394. PubMed ID: 33428785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.